(Q46537676)

English

Changes in insulin sensitivity and glucose metabolism during therapy with recombinant human growth hormone in short children born small for gestational age show a negative correlation with baseline measurements

scientific article published in April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18556964

Changes in insulin sensitivity and glucose metabolism during therapy with recombinant human growth hormone in short children born small for gestational age show a negative correlation with baseline measurements (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18556964

author name string

Chatelain P

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18556964

Crabbé R

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18556964

Saunders H

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18556964

von Holtey M

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18556964

publication date

1 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18556964

Journal of Pediatric Endocrinology and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18556964

21

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18556964

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18556964

329-338

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18556964

Persistent short stature, other potential outcomes, and the effect of growth hormone treatment in children who are born small for gestational age.

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.4.329

21 January 2018

Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.4.329

21 January 2018

Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.4.329

21 January 2018

Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.4.329

21 January 2018

Final height in short children born small for gestational age treated with growth hormone

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.4.329

21 January 2018

Carbohydrate metabolism during long-term growth hormone treatment in children with short stature born small for gestational age.

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.4.329

21 January 2018

High-dose growth hormone (GH) treatment in non-GH-deficient children born small for gestational age induces growth responses related to pretreatment GH secretion and associated with a reversible decrease in insulin sensitivity

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.4.329

21 January 2018

Reduced insulin sensitivity during growth hormone therapy for short children born small for gestational age.

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.4.329

21 January 2018

International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001.

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.4.329

21 January 2018

Reduced insulin sensitivity and the presence of cardiovascular risk factors in short prepubertal children born small for gestational age (SGA).

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.4.329

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.4.329

21 January 2018

A lifetime asymptotic growth curve for human height

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.4.329

21 January 2018

Effect of discontinuation of growth hormone treatment on risk factors for cardiovascular disease in adolescents born small for gestational age.

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.4.329

21 January 2018

Puberty decreases insulin sensitivity

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.4.329

21 January 2018

The somatotropic axis in short children born small for gestational age: relation to insulin resistance

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.4.329

21 January 2018

Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: relative roles of growth hormone and IGF-1 in insulin resistance

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.4.329

21 January 2018

Insulin-like growth factor I (rhIGF-I) as a therapeutic agent for hyperinsulinemic insulin-resistant diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.4.329

21 January 2018

Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.4.329

21 January 2018

Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats.

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.4.329

21 January 2018

The Effects of Repeated Daily Recombinant Human Insulin-like Growth Factor I Administration in Adolescents with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2008.21.4.329

21 January 2018

Identifiers

10.1515/JPEM.2008.21.4.329

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18556964

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18556964

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46537676&oldid=2116929923"